Ignite Creation Date:
2025-12-25 @ 12:32 AM
Ignite Modification Date:
2025-12-25 @ 10:40 PM
Study NCT ID:
NCT03556267
Status:
COMPLETED
Last Update Posted:
2021-02-16
First Post:
2018-05-19
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Regional Anesthesia of Cesarean Section
Sponsor:
Cairo University
Organization:
Study Overview
Official Title:
Role of Beta Trace Protein Assay During Spinal Anesthesia of Cesarean Section
Status:
COMPLETED
Status Verified Date:
2021-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Beta trace protein assay is an indicator of post-spinal CSF leak that predicts the degree of post-spinal headache.
Detailed Description:
Beta trace protein is specific for CSF only and it is a quantitative analytic test.
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: